This review emphasizes the need for rigorous experimental design and appropriate animal model selection to improve the clinical translation of myocardial infarction therapies.
No takes yet. Share an insight, caveat, or question.
Clinicians should treat preclinical MI therapy results as hypothesis-generating only; leaves open better disease models to enable successful translation.
Shin et al. (2021) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: